9-(2-hydroxy-3-nonyl)adenine has been researched along with Hypertrophy, Left Ventricular in 1 studies
9-(2-hydroxy-3-nonyl)adenine: specific inhibitor of adenosine deaminase
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Q | 1 |
| Lazar, M | 1 |
| Molino, B | 1 |
| Rodriguez, R | 1 |
| Davidov, T | 1 |
| Su, J | 1 |
| Tse, J | 1 |
| Weiss, HR | 1 |
| Scholz, PM | 1 |
1 other study available for 9-(2-hydroxy-3-nonyl)adenine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Reduction in interaction between cGMP and cAMP in dog ventricular myocytes with hypertrophic failure.
Topics: Adenine; Animals; Body Weight; Cardiotonic Agents; Cyclic AMP; Cyclic GMP; Dogs; Drug Interactions; | 2005 |